The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 151 page report you will receive 124 charts – all unavailable elsewhere.
The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Drug-Device Combination Market forecasts from 2017-2027
• Revenue forecast for the drug-device combination market by End-Users:
– Hospitals & clinics
– Emergency service centers
– Ambulatory surgical centers
– Home care settings
Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World
• Revenue forecast for the drug-device combination market by Products:
– Drug eluting stents
– Photosensitizers
– Orthopaedic products
– Infusion pumps
– Wound care products
– Transmucosal products
– Transdermal patches
– Others
Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World
• This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
– North America: The U.S and Rest of North America
– Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
– Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
– Rest of the world (RoW): Latin America, and Middle East and African countries
Each regional market is further divided by end-users and products
• This report discusses the leading companies in the global drug-device combination market:
– Medtronic
– Boston Scientific Corporation
– Stryker Corporation
– Ethicon Inc
– C.R. Bard Inc.
– Medline Industries Inc.
– Mylan Inc.
– Terumo Corporation
– Pinnacle Biologics Inc.
– W. L. Gore & Associates, Inc.
• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global drug-device combination market
Visiongain’s study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.
Buy our report today Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Drug-Device Combination Market Overview
1.2 Why You Should Read This Report
1.3 Key Questions Answered by This Analytical Report
1.4 Who is This Report For?
1.5 Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2. Drug-Device Combination Market Definition
2.1 What are Drug-Device Combination Products?
2.2 Types of Drug-Device Combination Products
2.2.1 Drug Eluting Stents
2.2.2 Photosensitizers
2.2.3 Orthopedic Products
2.2.4 Infusion Pumps
2.2.5 Wound Care Products
2.2.6 Transmucosal Products
2.2.7 Transdermal Products
2.3 Drug-Devices Combination Market Structure
2.4 Classification of Drug-Devices Combination Market
3. Drug-Device Combination Market: Global Market by End-Users 2017-2027
3.1 Hospitals & Clinics Submarket Forecast & Analysis 2017-2027
3.2 Emergency Service Centers Submarket Forecast & Analysis 2017-2027
3.3 Ambulatory Surgical Centers Submarket Forecast & Analysis 2017-2027
3.4 Home Care Settings Submarket Forecast & Analysis 2017-2027
4. Drug-Device Combination: Global Market by Products 2017-2027
4.1 Drug Eluting Stents Submarket Forecast & Analysis 2017-2027
4.2 Photosensitizers Submarket Forecast & Analysis 2017-2027
4.3 Orthopedic Products Submarket Forecast & Analysis 2017-2027
4.4 Infusion Pumps Submarket Forecast & Analysis 2017-2027
4.5 Wound Care Products Submarket Forecast & Analysis 2017-2027
4.6 Transmucosal Products Submarket Forecast & Analysis 2017-2027
4.7 Transdermal Products Submarket Forecast & Analysis 2017-2027
4.8 Other Combination Products Submarket Forecast & Analysis 2017-2027
5. Regional Drug-Device Combination Market Forecasts 2017-2027
5.1 Regional Drug-Device Combination Market Forecasts 2017-2027
5.2 North American Drug-Devices Combination Market Forecasts 2017-2027
5.2.1 U.S. Drug-Devices Combination Market Forecasts 2017-2027
5.2.2 Rest of North America Drug-Device Combination Market Forecasts 2017-2027
5.3 North American Drug-Device Combination Market Forecasts by Products 2017-2027
5.4 North American Drug-Device Combination Market Forecasts by End-Users 2017-2027
5.5 Europe Drug-Device Combination Market Forecasts 2017-2027
5.5.1 France Drug-Device Combination Market Forecasts 2017-2027
5.5.2 Germany Drug-Device Combination Market Forecasts 2017-2027
5.5.3 U.K. Drug-Device Combination Market Forecasts 2017-2027
5.5.4 Spain Drug-Device Combination Market Forecasts 2017-2027
5.5.5 Italy Drug-Device Combination Market Forecasts 2017-2027
5.5.6 Russia Drug-Device Combination Market Forecasts 2017-2027
5.5.7 Rest of Europe Drug-Device Combination Market Forecasts 2017-2027
5.6 European Drug-Device Combination Market Forecasts by Products 2017-2027
5.7 European Drug-Device Combination Market Forecasts by End-Users 2017-2027
5.8 Asia-Pacific Drug-Device Combination Market Forecasts 2017-2027
5.8.1 China Drug-Device Combination Market Forecasts 2017-2027
5.8.2 India Drug-Device Combination Market Forecasts 2017-2027
5.8.3 Japan Drug-Device Combination Market Forecasts 2017-2027
5.8.4 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts 2017-2027
5.9 Asia-Pacific Drug-Device Combination Market Forecasts by Products 2017-2027
5.10 Asia-Pacific Drug-Device Combination Market Forecasts by End-Users 2017-2027
5.11 Rest of the World (RoW) Drug-Device Combination Market Forecasts 2017-2027
5.11.1 Latin America Drug-Device Combination Market Forecasts 2017-2027
5.11.2 Middle East and Africa Drug-Device Combination Market Forecasts 2017-2027
5.12 Rest of the World (RoW) Drug-Device Combination Market Forecasts by Products 2017-2027
5.13 Rest of the World (RoW) Drug-Device Combination Market Forecasts by End-Users 2017-2027
6. Drivers & Restraints
6.1 Drivers and Restraints 2017-2027
6.2 Drivers
6.2.1 Increasing Initiatives by Government and NGO in Support of Drug Delivery Implants
6.2.2 Rising popularity of minimally invasive surgeries
6.2.3 Increasing Prevalence of Chronic Disorders
6.2.4 Technological Innovations and Advancements
6.3 Restraints
6.3.1 Recall of Combination Products Due to Adverse Effects
6.3.2 High Cost of Combination Products
6.3.3 Regulatory and Technical Challenges Pertaining to Combination Products
7. Leading Companies in the Drug-Devices Combination Market
7.1 Medtronic
7.1.1 Medtronic Business Overview
7.1.2 Medtronic Financial Overview
7.1.3 Medtronic Product Portfolio
7.1.4 Medtronic Corporate Strategy
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Business Overview
7.2.2 Boston Scientific Corporation Financial Overview
7.2.3 Boston Scientific Corporation Corporate Strategy
7.2.4 Boston Scientific Corporation Product Portfolio
7.3 Stryker Corporation
7.3.1 Stryker Corporation Business Overview
7.3.2 Stryker Corporation Financial Overview
7.3.3 Stryker Corporation Product Portfolio
7.3.4 Stryker Corporation Corporate Strategy
7.4 Ethicon Inc.
7.4.1 Ethicon Inc. Business Overview
7.4.2 Ethicon Inc. Financial Overview
7.4.3 Ethicon Inc. Corporate Strategy
7.4.4 Ethicon Inc. Product Portfolio
7.5 C. R. Bard Inc.
7.5.1 C. R. Bard Inc. Business Overview
7.5.2 C. R. Bard Inc. Financial Overview
7.5.3 C.R. Bard Inc. Corporate Strategy
7.5.4 C.R. Bard Inc. Product Portfolio
7.6 Medline Industries Inc.
7.6.1 Medline Industries Inc. Business Overview
7.6.2 Medline Industries Inc. Financial Overview
7.6.3 Medline Industries Inc. Corporate Strategy
7.7 Mylan Inc.
7.7.1 Mylan Inc. Business Overview
7.7.2 Mylan Inc. Financial Overview
7.7.3 Mylan Inc. Corporate Strategy
7.7.4 Mylan Inc. Product Portfolio
7.8 Terumo Corporation
7.8.1 Terumo Corporation Business Overview
7.8.2 Terumo Corporation Financial Overview
7.8.3 Terumo Corporation Corporate Strategy
7.8.4 Terumo Corporation Product Portfolio
7.9 Pinnacle Biologics Inc.
7.9.1 Pinnacle Biologics Inc. Business Overview
7.9.2 Pinnacle Biologics Inc. Financial Overview
7.9.3 Pinnacle Biologics Corporate Strategy
7.9.4 Pinnacle Biologics Product Portfolio
7.10 W.L. Gore & Associates Inc.
7.10.1 W.L. Gore & Associates Inc. Business Overview
7.10.2 W.L. Gore Associates & Inc. Financial Overview
7.10.3 W.L. Gore Associates & Inc. Corporate Strategy
7.10.4 W.L. Gore Associates & Inc. Product Portfolio
8. Qualitative Analysis of the Drug-Device Combination Market
8.1 Porter’s Five Forces Analysis of the Drug-Device Combination Market
8.2 Rivalry among Competitors [High]
8.3 Threat of New Entrants [Medium]
8.4 Power of Suppliers [Low]
8.5 Power of Buyers [Medium]
8.6 Threat of Substitutes [Medium]
9. Conclusions
9.1 Current Leading Drug-Device Combination Market Segments
9.1.1 Leading Drug-Device Combination Products Companies
9.1.2 Leading Regional Markets
9.1.3 Emerging Drug-Device Combination Products Markets
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 2.1 Global Drug-Devices Combination Market Segmentation Overview, 2017
Figure 3.1 Global Drug-Device Combination Market by End-Users, 2016, (% Share)
Figure 3.2 Drug-Device Combination Submarkets, by End-Users, Forecast ($bn) 2016-2027
Figure 3.3 Hospital and Clinics Market Forecasts, by % AGR 2017-2027
Figure 3.4 Global Hospitals & Clinics Market by Region, 2016-2027
Figure 3.5 Global Hospitals & Clinics Market Share, by Region, (% Share) 2016-2027
Figure 3.6 Emergency Service Centers Submarkets Forecasts, by % AGR 2017-2027
Figure 3.7 Global Emergency Service Centers Market by Region, 2016-2027
Figure 3.8 Global Emergency Service Centers Market Share, by Region, (% Share) 2016-2027
Figure 3.9 Ambulatory Surgical Centers Submarkets Forecasts, by % AGR 2017-2027
Figure 3.10 Global Physician Offices Market by Region, 2016-2027
Figure 3.11 Global Physician Offices Market Share, by Region, (% Share) 2016-2027
Figure 3.12 Home Care Settings Submarkets Forecasts, by % AGR 2017-2027
Figure 3.13 Global Home Care Settings Market by Region, 2016-2027
Figure 3.14 Global Home Care Settings Market Share, by Region, (% Share) 2016-2027
Figure 4.1 Global Drug-Device Combination Market by Products, 2016, (% Share)
Figure 4.2 Drug-Device Combination Submarkets, by Products Type, Forecast ($bn) 2016-2027
Figure 4.3 Drug Eluting Stent Market Forecasts, by % AGR 2017-2027
Figure 4.4 Global Drug Eluting Stent Market by Region, 2016-2027
Figure 4.5 Global Drug Eluting Stent Market Share, by Region, (% Share) 2016-2027
Figure 4.6 Photosensitizers Submarkets Forecasts, by % AGR 2017-2027
Figure 4.7 Global Photosensitizers Market by Region, 2016-2027
Figure 4.8 Global Photosensitizers Market Share, by Region, (% Share) 2016-2027
Figure 4.9 Orthopedic Products Submarkets Forecasts, by % AGR 2017-2027
Figure 4.10 Global Orthopedic Products Market by Region, 2016-2027
Figure 4.11 Global Orthopedic Products Market Share, by Region, (% Share) 2016-2027
Figure 4.12 Infusion Pumps Submarkets Forecasts, by % AGR 2017-2027
Figure 4.13 Global Infusion Pumps Market by Region, 2016-2027
Figure 4.14 Global Infusion Pumps Market Share, by Region, (% Share) 2016-2027
Figure 4.15 Wound Care Products Submarkets Forecasts, by % AGR 2017-2027
Figure 4.16 Global Wound Care Products Market by Region, 2016-2027
Figure 4.17 Global Wound Care Products Market Share, by Region, (% Share) 2016-2027
Figure 4.18 Transmucosal Products Submarkets Forecasts, by % AGR 2017-2027
Figure 4.19 Global Transmucosal Products Market by Region, 2016-2027
Figure 4.20 Global Transmucosal Products Market Share, by Region, (% Share) 2016-2027
Figure 4.21 Transdermal Products Submarkets Forecasts, by % AGR 2017-2027
Figure 4.22 Global Transdermal Products Market by Region, 2016-2027
Figure 4.23 Global Transdermal Products Market Share, by Region, (% Share) 2016-2027
Figure 4.24 Other Combination Products Submarkets Forecasts, by % AGR 2017-2027
Figure 4.25 Global Other Combination Products Market by Region, 2016-2027
Figure 4.26 Global Other Combination Products Market Share, by Region, (% Share) 2016-2027
Figure 5.1 Regional Drug-Device Combination Market Forecasts ($bn), 2017-2027
Figure 5.2 Regional Drug-Device Combination Market Share (%), 2016
Figure 5.3 North American Drug-Devices Combination Market Share Analysis, by Country ($bn, AGR%), 2016
Figure 5.4 U.S. Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.5 Rest of North America Pharma Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.6 North American Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
Figure 5.7 North American Cancer Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
Figure 5.8 European Pharma Clinical Trial Services Market Share Analysis, by Country ($bn, AGR%), 2016
Figure 5.9 France Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.10 Germany Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.11 U.K. Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.12 Spain Pharma Clinical Trial Services Market Forecasts ($bn), 2016-2027
Figure 5.13 Italy Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.14 Russia Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.15 Rest of Europe Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.16 European Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
Figure 5.17 European Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
Figure 5.18 Asia-Pacific Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016
Figure 5.19 China Drug-Device Market Forecasts ($bn), 2016-2027
Figure 5.20 India Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.21 Japan Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.22 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.23 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
Figure 5.24 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
Figure 5.25 Rest of the World (RoW) Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016-2027
Figure 5.26 Latin America Drug-Device Combination Market Forecasts ($mn), 2016-2027
Figure 5.27 Middle East and Africa Drug-Device Combination Market Forecasts ($bn), 2016-2027
Figure 5.28 RoW Drug-Devices Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
Figure 5.29 RoW Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
Figure 6.1 Market: Drivers and Restraints, 2017-2027
Figure 7.1 Medtronic 2016 Annual Revenue by Business Segments
Figure 7.2 Medtronic Annual Revenue 2012- 2016 ($mn)
Figure 7.3 Boston Scientific Corporation 2016 Annual Revenue by Business Segments
Figure 7.4 Boston Scientific Corporation Annual Revenue 2012- 2016 ($mn)
Figure 7.5 Stryker Corporation 2016 Annual Revenue by Business Segments
Figure 7.6 Stryker Corporation Annual Revenue 2012- 2016 ($mn)
Figure 7.7 Johnson & Johnson 2016 Annual Revenue by Business Segments
Figure 7.8 Johnson & Johnson Annual Revenue 2012- 2016 ($mn)
Figure 7.9 C.R. Bard Inc. 2016 Annual Revenue by Business Segments
Figure 7.10 C. R. Bard Inc. Annual Revenue 2012- 2016 ($mn)
Figure 7.11 Mylan Inc. 2016 Annual Revenue by Business Segments
Figure 7.12 Mylan Inc. Annual Revenue 2012- 2016 ($mn)
Figure 7.13 Terumo Corporation 2016 Annual Revenue by Business Segments
Figure 7.14 Terumo Corporation Annual Revenue 2012- 2016 ($mn)
Figure 8.1 Porter’s Five Forces Analysis of the Drug-Device Combination Market, 2017-2027
List of Tables
Table 3.1 Drug-Device Combination Products Submarkets, by End-Users Forecast ($bn, CAGR%)
Table 3.2 Hospitals/Clinical Laboratories Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 3.3 Emergency Service Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 3.4 Ambulatory Surgical Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 3.5 Home Care Settings markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.1 Drug-Device Combination Submarkets, by Products Type Forecast ($bn, CAGR%)
Table 4.2 Drug Eluting Stent Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.3 Photosensitizers Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.4 Orthopedic Products markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.5 Infusion Pumps Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.6 Wound Care Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.7 Transmucosal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.8 Transdermal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 4.9 Other Combination Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
Table 5.1 Regional Drug-Devices Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.2 U.S. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.3 Rest of North America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.4 North American Drug-Device Combination Market Forecasts, by Products Type ($bn, AGR% CAGR%) 2016-2027
Table 5.5 North American Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
Table 5.6 France Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.7 Germany Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.8 U.K. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.9 Spain Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.10 Italy Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.11 Russia Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.12 Rest of Europe Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.13 European Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
Table 5.14 European Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
Table 5.15 China Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.16 India Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.17 Japan Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.18 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.19 Asia-Pacific Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
Table 5.20 Asia-Pacific Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
Table 5.21 Latin America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.22 Middle East and Africa Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
Table 5.23 RoW Pharma Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
Table 5.24 RoW Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
